Position in PFE
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$4,008,116
+$2,182,916 QoQ
Shares Held
166,450
+156.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#684
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PKO Investment Management Joint-Stock Co holds $45,805,043 across 9 Drug Manufacturers - General names. PFE ranks #6 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,750 | $10,495,013 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
58,500 | $7,390,890 | |
| 3 | JNJ |
Johnson & Johnson
|
28,200 | $7,161,954 | |
| 4 | AMGN |
Amgen Inc
|
16,400 | $5,938,768 | |
| 5 | ABBV |
AbbVie Inc.
|
21,200 | $5,334,768 | |
| 6 | PFE |
Pfizer Inc
This page
|
166,450 | $4,008,116 | |
| 7 | MRK |
Merck & Co., Inc.
|
30,000 | $3,855,000 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
21,000 | $1,210,020 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,008,116 | 166,450 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,825,200 | 65,000 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $2,066,700 | 83,000 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $2,293,200 | 90,000 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $2,181,600 | 90,000 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,381,960 | 94,000 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $2,095,870 | 79,000 | Shares | Sole | 2025-03-13 | |
| 2024-09-30 | $2,821,186 | 97,484 | Shares | Sole | 2025-03-13 | |
| 2024-06-30 | $2,727,602 | 97,484 | Shares | Sole | 2025-03-13 | |
| 2024-03-31 | $2,899,431 | 104,484 | Shares | Sole | 2025-03-13 | |
| 2023-12-31 | $3,612,684 | 125,484 | Shares | Sole | 2025-03-13 | |
| 2023-09-30 | $4,029,624 | 121,484 | Shares | Sole | 2025-03-13 | |
| 2023-06-30 | $4,456,033 | 121,484 | Shares | Sole | 2025-03-13 | |
| 2023-03-31 | $4,956,547 | 121,484 | Shares | Sole | 2025-03-13 | |
| 2022-12-31 | $4,328,960 | 84,484 | Shares | Sole | 2025-03-13 | |
| 2022-09-30 | $3,959,579 | 90,484 | Shares | Sole | 2025-03-13 | |
| 2022-06-30 | $5,640,733 | 107,586 | Shares | Sole | 2025-03-13 | |
| 2022-03-31 | $6,087,427 | 117,586 | Shares | Sole | 2025-03-13 | |
| 2021-12-31 | $7,486,713 | 126,786 | Shares | Sole | 2025-03-13 | |
| 2021-09-30 | $7,086,413 | 164,762 | Shares | Sole | 2025-03-13 | |
| 2021-06-30 | $4,727,356 | 120,719 | Shares | Sole | 2025-03-13 | |
| 2021-03-31 | $1,774,835 | 48,988 | Shares | Sole | 2025-03-13 | |
| 2020-12-31 | $1,803,248 | 48,988 | Shares | Sole | 2025-03-13 | |
| 2020-09-30 | $1,797,857 | 48,988 | Shares | Sole | 2025-03-13 | |
| 2020-06-30 | $1,601,909 | 48,988 | Shares | Sole | 2025-03-13 | |
| 2020-03-31 | $1,598,966 | 48,988 | Shares | Sole | 2025-03-13 | |
| No filing history on record for this holder in this stock. | ||||||